Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
Two new immunizations could protect babies from RSV, the leading cause of hospitalization in infants.
These hurdles threaten to prevent babies from receiving protection this winter and to hinder the launches of both drugs. RSV typically feels like a cold for adults but can be dangerous for newborns, seniors and adults with chronic medical conditions. Complications from the virus are the leading cause of hospitalization among newborns.
"Whether it's a neighbor, or a friend, or an older sibling that was hospitalized, everybody knows what is," said Erin Bakke, whose 4-month-old son Graham received a Beyfortus shot this week. "I know that 's a threat to little babies, and so to have an opportunity to prevent illness in the first place is really exciting.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New RSV protections for infants hit cost, insurance hurdles in U.S. rolloutPfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier…
Read more »
Pfizer Wins FDA Approval for New Ulcerative Colitis PillThe treatment is one of a number of new products that the company expects to bring in a combined $20 billion in potential annual revenue by 2030.
Read more »
Alaska Department of Health recommends RSV vaccine for pregnant womenAlaska Dept. of Health recommends RSV vaccine for pregnant women.
Read more »
Pharmacists recommending everyone over 60 get the RSV vaccine this seasonLocal pharmacists are recommending RSV vaccines for everyone 60 and over.
Read more »
Prepping for the flu/RSV season as cases begin to increaseFlu season starting to escalate.
Read more »
RSV antibody shot for babies hits obstacles in rollout: 'As pediatricians, we're angry'RSV season is ramping up, but some doctors are facing challenges getting ahold of a shot that can help protect young children.
Read more »